Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weber, K. Articles by Ruhnke, M. Search for Related Content PubMed PubMed Citation Articles by Weber, K. Articles by Ruhnke, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2008, p. 1859-1861, Vol. 52, No. 5
0066-4804/08/$08.00+0     doi:10.1128/AAC.01646-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Secretion of E,E-Farnesol and Biofilm Formation in Eight Different Candida Species

K. Weber,¹ R. Sohr,² B. Schulz,¹ M. Fleischhacker,¹ and M. Ruhnke^1*

Division of Oncology and Hematology, Department of Medicine,¹ Institute of Pharmacology, Charité—Universitätsmedizin Berlin, Berlin, Germany²

Received 21 December 2007/ Returned for modification 20 January 2008/ Accepted 2 March 2008

Top ABSTRACT TEXT REFERENCES

 
Production of E,E-farnesol (FOH) and biofilm formation were studied under various conditions in 56 strains of eight Candida spp. FOH production differed significantly not only between Candida spp. but within Candida albicans strains as well. FOH concentrations and biofilm formation were the highest for C albicans.

Top ABSTRACT TEXT REFERENCES

 
Candida albicans is a major human fungal pathogen, causing both superficial and invasive tissue infections. The ability of C. albicans to form biofilms on medical devices has a profound impact on its capacity to cause human disease. C. albicans and other members of the genus Candida are able to grow in different forms as budding yeast, pseudohyphae, and true hyphae, which is called dimorphism (1, 8). This transition from yeast to hyphal growth can be induced by various conditions (2, 25). Progression to a mature biofilm is dependent on cell adhesion, extracellular matrix production, and the yeast-to-hypha transition in C. albicans (2, 3). However, biofilm development in non-C. albicans Candida spp. (NCAC) is not well understood.

Suppression of biofilm formation in C. albicans may be achieved by quorum-sensing molecules (5). E,E-Farnesol (FOH) has been reported to inhibit the induction of hyphal growth and biofilm formation in C. albicans (10, 11). In this study, FOH secretion by C. albicans and eight NCAC was examined under various culture conditions. In addition, the development of biofilms was studied. Finally, the correlation between FOH secretion and biofilm formation was analyzed for all of the isolates studied.

We studied 56 strains of eight Candida species (Table 1). All isolates were cultivated in RPMI 1640 medium with or without the addition of 10% fetal calf serum (FCS) at 37°C for 24 h under continuous rotation at 125 rpm. Two milliliters of sterile filtered (0.45 µm) culture supernatant was extracted with 5 ml n-hexane-ethanol (90:10, vol/vol) and derivatized with 9-anthroylnitrile as previously described (13). Quantification was done with n-butanol as an internal standard (50 ng added to each sample). Reverse-phase high-performance liquid chromatography was done with a YMC Hydrosphere C₁₈ column (5 µm, 150 by 2.1 mm [inside diameter]). A linear gradient of acetonitrile-water (85% to 100% over 20 min) was used as the mobile phase. Standard concentrations ranged from 0.004 µM to 40 µM FOH. Detection, determination of recovery, and calculations were performed as previously described (4, 13). The development of biofilms by all of the Candida spp. was studied according to Krom et al. (6), with minor differences such as using 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt instead of 2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide. In addition to visual reading at 450 nm, optical density was measured at 405 nm for data validation (15). All tests were done twice and analyzed with the two-tailed paired Student t test comparing 0 and 10% FCS cultivations (significance was set at a P value of 0.05).

View this table: [in this window] [in a new window]

TABLE 1. Candida spp. used in this study and concentrations of secreted FOH

The quantification and standardization of FOH showed good linearity with R² = 0.99. The recovery rate was determined as approximately 95%. The FOH concentrations for all 56 Candida strains are shown in Table 1. Under FCS-free conditions, the highest concentrations of FOH were measured for C. albicans isolates, with a mean of 35.6 µM (range, 13.7 to 58.5 µM). The quantity was up to 35 times higher than for NCAC, except for C. dubliniensis. The mean FOH concentration for C. dubliniensis was 8.3 µM (range, 6.0 to 17.5 µM). Individual C. albicans isolates varied remarkably in their ability to produce FOH. FOH concentrations were almost four times as high as for C. dubliniensis. All other NCAC showed relatively low concentrations of FOH (mean, 0.6 ± 0.2 µM), independently of whether the Candida strains were cultivated with or without supplementation with 10% FCS.

Significant decreases in the secretion of FOH were observed for C. albicans (P = 0.001), C. dubliniensis (P = 0.0007), and C. guilliermondii (P = 0.01) under FCS-supplemented culture conditions. The concentration of FOH for C. albicans decreased to 2.0 ± 0.9 µM (mean). The comparison of the FCS-free and 10% FCS cultivations indicated a significant disparity (P = 0.003).

The investigation of biofilm formation showed comparable results for both techniques (Fig. 1). An optical density cutoff of 0.2 (>35% transmission blocked) was used to discriminate biofilm producers according to recent suggestions (14, 15). With both media, C. albicans and C. dubliniensis formed good biofilms. C. dubliniensis isolates produced 48% more biofilm under FCS-free conditions than did C. albicans (no statistically significant difference). Addition of 10% FCS to the growth medium induced significantly better biofilm formation in five of the eight Candida species tested (Fig. 1; P < 0.05). With C. albicans, increased biofilm formation (by 76%) was observed with 10% FCS in the medium. Increased biofilm formation was also obtained for C. dubliniensis (34%), C. tropicalis (34%), and C. krusei (61%).

View larger version (19K): [in this window] [in a new window]

FIG. 1. Biofilm formation by Candida species. Fifty-six Candida spp. were incubated for 24 h in RPMI 1640 medium containing 0% (A) or 10% (B) FCS. Biofilm formation was measured as described in the text. The average for all of the isolates of a species in Table 1 is shown as the result of 14 values calculated for each column. *, Significantly increased biofilm (P < 0.05) when cultured in medium with 10% FCS. WST-1, 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt.

Quorum-sensing molecules, and FOH in particular, are considered to play an important role in the development of biofilms by C. albicans on the surfaces of medical devices (10-12). In this study, we found that C. dubliniensis can produce significant amounts of FOH but still less than C. albicans. In contrast, biofilm formation was more pronounced in C. dubliniensis than in any of the other Candida spp. tested. It is unclear whether this is related to the phylogenetic relationship between the two species or to other conditions (7). C. dubliniensis is a rare human pathogen and causes much less common invasive Candida infections in humans than do C. albicans and other NCAC. Furthermore, we have observed that several other NCAC do not produce any notable FOH but may form a biofilm (e.g., C. tropicalis, C. parapsilosis). The mechanism of reduced FOH production after supplementation with 10% FCS is unclear, but it is known that culture conditions may affect the global transcriptional response of Candida spp. (C. albicans) (9). It is assumed that the ability to form a biofilm is linked to FOH secretion as the major quorum-sensing molecule in C. albicans and C. dubliniensis, as shown in this study. We found that other Candida spp. can form biofilms without high levels of FOH, and it may be concluded that these NCAC use other pathways or quorum-sensing molecules for biofilm formation without FOH secretion.

Biofilm formation by NCAC is not well understood and requires further exploration with other models (e.g., gene regulation, detection of regulatory pathways).

 
* Corresponding author. Mailing address: Charité—Universitätsmedizin Berlin, Department of Medicine, Division of Oncology and Hematology, Charitéplatz 1, 10117 Berlin, Germany. Phone: 49 (30) 450 51 30 36. Fax: 49 (30) 450 51 39 37. E-mail: markus.ruhnke{at}charite.de

Published ahead of print on 10 March 2008.

Top ABSTRACT TEXT REFERENCES

 

1
1. Calderone, R. A. 2002. Taxonomy and biology of Candida, p. 15-28. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, DC.
2
2. Calderone, R. A., and W. A. Fonzi. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9:327-335.[CrossRef][Medline]
3
3. Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.[CrossRef][Medline]
4
4. Glowka, F. K., M. Karazniewicz, and E. Lipnicka. 2006. RP-HPLC method with fluorescence detection for determination of small quantities of triamcinolone in plasma in presence of endogenous steroids after derivatization with 9-anthroyl nitrile; pharmacokinetic studies. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 839:54-61.[CrossRef][Medline]
5
5. Hornby, J. M., and E. C. Jensen. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992.[Abstract/Free Full Text]
6
6. Krom, B. P., J. B. Cohen, G. E. Elhaney Feser, and R. L. Cihlar. 2007. Optimized candidal biofilm microtiter assay. J. Microbiol. Methods 68:421-423.[CrossRef][Medline]
7
7. Mähnss, B., F. Stehr, W. Schafer, and K. Neuber. 2005. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis. Mycoses 48:55-61.[CrossRef][Medline]
8
8. Mitchell, A. P. 1998. Dimorphism and virulence in Candida albicans. Curr. Opin. Microbiol. 1:687-692.[CrossRef][Medline]
9
9. Murillo, L. A., G. Newport, C. Y. Lan, S. Habelitz, J. Dungan, and N. M. Agabian. 2005. Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans. Eukaryot. Cell 4:1562-1573.[Abstract/Free Full Text]
10
10. Nickerson, K. W., A. L. Atkin, and J. M. Hornby. 2006. Quorum sensing in dimorphic fungi: farnesol and beyond. Appl. Environ. Microbiol. 72:3805-3813.[Free Full Text]
11
11. Ramage, G., S. P. Saville, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463.[Abstract/Free Full Text]
12
12. Ramage, G., K. VandeWalle, B. L. Wickes, and J. L. López-Ribot. 2001. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18:163-170.[Medline]
13
13. Saisho, Y., A. Morimoto, and T. Umeda. 1997. Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. Anal. Biochem. 252:89-95.[CrossRef][Medline]
14
14. Shin, J. H., S. J. Kee, M. G. Shin, S. H. Kim, D. H. Shin, S. K. Lee, S. P. Suh, and D. W. Ryang. 2002. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J. Clin. Microbiol. 40:1244-1248.[Abstract/Free Full Text]
15
15. Tumbarello, M., B. Posteraro, E. M. Trecarichi, B. Fiori, M. Rossi, R. Porta, K. de Gaetano Donati, M. La Sorda, T. Spanu, G. Fadda, R. Cauda, and M. Sanguinetti. 2007. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J. Clin. Microbiol. 45:1843-1850.[Abstract/Free Full Text]

---

Antimicrobial Agents and Chemotherapy, May 2008, p. 1859-1861, Vol. 52, No. 5
0066-4804/08/$08.00+0     doi:10.1128/AAC.01646-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Jarosz, L. M., Deng, D. M., van der Mei, H. C., Crielaard, W., Krom, B. P. (2009). Streptococcus mutans Competence-Stimulating Peptide Inhibits Candida albicans Hypha Formation. Eukaryot Cell 8: 1658-1664 [Abstract] [Full Text]  
• Shirtliff, M. E., Krom, B. P., Meijering, R. A. M., Peters, B. M., Zhu, J., Scheper, M. A., Harris, M. L., Jabra-Rizk, M. A. (2009). Farnesol-Induced Apoptosis in Candida albicans. Antimicrob. Agents Chemother. 53: 2392-2401 [Abstract] [Full Text]  
• Rossignol, T., Ding, C., Guida, A., d'Enfert, C., Higgins, D. G., Butler, G. (2009). Correlation between Biofilm Formation and the Hypoxic Response in Candida parapsilosis. Eukaryot Cell 8: 550-559 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weber, K. Articles by Ruhnke, M. Search for Related Content PubMed PubMed Citation Articles by Weber, K. Articles by Ruhnke, M.